Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by westcoast1000on Feb 12, 2023 6:41pm
197 Views
Post# 35282326

RE:A little decision analysis

RE:A little decision analysisOver on the Yahoo board, under the leadership of the tiresome big guy that many of us have been hearing from on Yahoo V2 for well over five years, the main sentiment is that the company is a scam that is manipulated to create a retirement for Matt. The main argument seems to be resentment over dilution over the last 5 years. That dilution has been substantial, but also led to some some very low share prices, so one could keep up with the diultion if you cared to do so.

They also argue that if nothing happens by the end of March the share price will be well below $1 and no one will want to buy shares. 

Is theirs a parallel world where people see everything inverted? I do not know. I do know that the results of last fall are irrefutable as an indicator of value for ONCY.  
<< Previous
Bullboard Posts
Next >>